SCHEMBL4590674

SCHEMBL4590674

O=C1C[C@@H]2CC[C@H]1C1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)[C@@H]12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.46
HTR1A P08908 1/20 0.46
DRD2 P14416 1/20 0.46
HTR2A P28223 1/20 0.46
HTR6 P50406 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 6/20 0.43
TSHR P16473 2/20 0.43
AR P10275 1/20 0.42
LMNA P02545 1/20 0.42
ALOX15 P16050 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5922838 1.00 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL3189345 1.00 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL5922841 1.00 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL3191008 0.88 KMT2A (0.46) MEN1KMT2AALDH1A1TSHRLMNA
SCHEMBL3191019 0.88 KMT2A (0.46) MEN1KMT2AALDH1A1TSHRLMNA
SCHEMBL3190995 0.88 KMT2A (0.46) MEN1KMT2AALDH1A1TSHRLMNA
SCHEMBL5922735 0.87 MEN1 (0.40) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL5922727 0.87 MEN1 (0.40) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL3187880 0.87 MEN1 (0.40) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL3178825 0.85 HTR1A (0.58) HTR7HTR1ADRD2HTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379249-A4 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2008-01-09 EP claimed
EP-1379249-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION Bristol-Myers Squibb Company (US) 2004-01-14 EP claimed
WO-2002067939-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-06 WO claimed